We are live on ! Find out more
AL

Aspiriant LLC Portfolio holdings

AUM $4.05B
1-Year Est. Return 19.01%
This Fund
S&P 500
This Quarter Est. Return
+5.8%
1 Year Est. Return
+19.01%
3 Year Est. Return
+47.13%
5 Year Est. Return
+48.95%
10 Year Est. Return
+147.53%
AUM
$1.87B
AUM Growth
+$168M
Cap. Flow
+$75.3M
Cap. Flow %
4.03%
Top 10 Hldgs %
59.38%
Holding
286
New
54
Increased
143
Reduced
45
Closed
6

Top Buys

Rank Stock Value
1
LDOS icon
Leidos
LDOS
+$12.7M
2
IJH icon
iShares Core S&P Mid-Cap ETF
IJH
+$6.85M
3
SAIC icon
Saic
SAIC
+$6.72M
4
VIG icon
Vanguard Dividend Appreciation ETF
VIG
+$4.91M
5
MSFT icon
Microsoft
MSFT
+$4.37M

Top Sells

Rank Stock Value
1
VBR icon
Vanguard Small-Cap Value ETF
VBR
+$8.47M
2
IUSV icon
iShares Core S&P US Value ETF
IUSV
+$3.92M
3
NET icon
Cloudflare
NET
+$2.37M
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$2.34M
5
ITIC
Investors Title Co
ITIC
+$1.31M

Sector Composition

Rank Sector Weight
1 Technology 10.2%
2 Financials 2.57%
3 Communication Services 2.19%
4 Healthcare 1.2%
5 Consumer Discretionary 0.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IWP icon
126
iShares Russell Mid-Cap Growth ETF
IWP
$19.6B
$1.1M 0.06%
9,575
– –
VOTE icon
127
TCW Transform 500 ETF
VOTE
$1.09B
$1.08M 0.06%
19,316
– –
IDV icon
128
iShares International Select Dividend ETF
IDV
$8.28B
$1.07M 0.06%
34,165
+11,342
+50% +$351K
VZ icon
129
Verizon
VZ
$201B
$1.05M 0.06%
20,216
+4,509
+29% +$235K
TSLA icon
130
Tesla
TSLA
$1.21T
$1.03M 0.06%
2,925
+600
+26% +$201K
ABBV icon
131
AbbVie
ABBV
$465B
$1.02M 0.05%
7,560
+227
+3% +$26.8K
TMO icon
132
Thermo Fisher Scientific
TMO
$214B
$1.01M 0.05%
1,509
+22
+1% +$13.7K
VO icon
133
Vanguard Mid-Cap ETF
VO
$107B
$1M 0.05%
15,696
+2,428
+18% +$152K
SLGN icon
134
Silgan Holdings
SLGN
$5.07B
$991K 0.05%
23,128
– –
ESGE icon
135
iShares ESG Aware MSCI EM ETF
ESGE
$6.41B
$987K 0.05%
+24,813
New +$1.02M
IUSG icon
136
iShares Core S&P US Growth ETF
IUSG
$31B
$987K 0.05%
8,546
+294
+4% +$32.8K
DXCM icon
137
DexCom
DXCM
$28.9B
$980K 0.05%
+7,300
New +$1.05M
NKE icon
138
Nike
NKE
$63.9B
$979K 0.05%
5,866
+728
+14% +$120K
QEMM icon
139
State Street SPDR MSCI Emerging Markets StrategicFactors ETF
QEMM
$53.3M
$973K 0.05%
14,379
– –
IBM icon
140
IBM
IBM
$214B
$958K 0.05%
7,179
+2,077
+41% +$261K
COST icon
141
Costco
COST
$429B
$956K 0.05%
1,684
+665
+65% +$341K
RTX icon
142
RTX Corp
RTX
$295B
– –
-11,973
Closed -$1.04M
BBH icon
143
VanEck Biotech ETF
BBH
$409M
$932K 0.05%
4,914
+674
+16% +$130K
SPT icon
144
Sprout Social
SPT
$522M
$918K 0.05%
10,123
-7,246
-42% -$821K
VXF icon
145
Vanguard Extended Market ETF
VXF
$30.5B
$893K 0.05%
+4,883
New +$918K
NEE icon
146
NextEra Energy
NEE
$186B
$848K 0.05%
9,083
+2,632
+41% +$227K
AMGN icon
147
Amgen
AMGN
$212B
$810K 0.04%
3,607
+478
+15% +$101K
QSR icon
148
Restaurant Brands International
QSR
$26B
$793K 0.04%
13,072
– –
SBUX icon
149
Starbucks
SBUX
$118B
$784K 0.04%
6,710
+3,896
+138% +$439K
VAW icon
150
Vanguard Materials ETF
VAW
$3.05B
$772K 0.04%
3,915
-45
-1% -$8.47K
4 5
6
7 8

Similar funds

ICP
Ilex Capital Partners London, United Kingdom $4.06B AUM 6.11% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
MGP
Metis Global Partners San Diego, California $4.07B AUM 30.82% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
BHC
Bowen Hanes & Co Ponte Vedra Beach, Florida $4.11B AUM 41.61% 1-Year Est. Return
MAM
Martingale Asset Management Boston, Massachusetts $3.99B AUM 22.65% 1-Year Est. Return

Aspiriant LLC's Q4 2021 Portfolio in Review

As of Q4 2021, Aspiriant LLC held 286 positions worth $1.87B, up 9.9% from $1.7B the previous quarter. Its ten largest holdings account for 59% of the portfolio.

Aspiriant LLC deployed $75.3M of net new capital in Q4 2021, opening 54 new positions and adding to 143 existing holdings. Its largest new stake was Leidos: 135,400 shares worth $12M.

By sector, the portfolio is most concentrated in Technology at 10% of assets, up from 8.8% a quarter earlier, followed by Financials and Communication Services.

On the sell side, the largest reduction was Vanguard Small-Cap Value ETF, an estimated $8.47M trimmed.

  • Aspiriant LLC's largest Q4 2021 buy was Leidos: 135,400 shares worth $12M.
  • Aspiriant LLC added most to iShares Core S&P Mid-Cap ETF in Q4 2021, an estimated $6.85M increase.
  • Aspiriant LLC's biggest Q4 2021 reduction was Vanguard Small-Cap Value ETF, cutting an estimated $8.47M.
  • Aspiriant LLC fully exited Investors Title Co in Q4 2021, selling an estimated $1.31M.
  • Aspiriant LLC's ten largest holdings make up 59% of its $1.87B portfolio in Q4 2021.
  • Aspiriant LLC opened 54 new positions and closed 6 in Q4 2021.
  • Aspiriant LLC's portfolio value rose 9.9% quarter-over-quarter to $1.87B.

Based on Aspiriant LLC's 13F filing for Q4 2021, filed 14 Feb 2022.